Thymopoietin: Difference between revisions

From Food & Medicine Encyclopedia

CSV import
Tag: Reverted
No edit summary
Tag: Manual revert
 
Line 31: Line 31:
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 13:19, 18 March 2025

Thymopoietin (also known as TMPO, LAP2, or Lamina-associated polypeptide 2) is a protein that in humans is encoded by the TMPO gene. It is a critical component of the nuclear structure and plays a vital role in cell division and cell cycle regulation.

Function[edit]

Thymopoietin is involved in the regulation of the cell cycle, specifically during the G2/M transition. It interacts with B-type lamins, which are integral components of the nuclear envelope. This interaction is crucial for the structural integrity of the nuclear envelope and the successful completion of cell division.

Clinical significance[edit]

Alterations in the expression or function of thymopoietin have been associated with several diseases. For example, mutations in the TMPO gene have been linked to Barth syndrome, a rare genetic disorder characterized by cardiomyopathy, neutropenia, and muscle weakness. Additionally, overexpression of thymopoietin has been observed in certain types of cancer, suggesting a potential role in tumorigenesis.

Research[edit]

Research into thymopoietin has provided valuable insights into the mechanisms of cell division and the pathogenesis of various diseases. It has potential therapeutic implications, particularly in the treatment of diseases associated with cell cycle dysregulation, such as cancer.

See also[edit]

References[edit]